"A clinical trial in Liberia of a drug to treat Ebola has been halted because of a sharp decline in the number of people infected with the virus,"
It says drug...not vaccine. So with a sharp decline in the number of people infected, the amount of diagnostic testing also goes down.
(0)
(0)
Nanologix Inc (NNLX) Stock Research Links
-
-
-
-
-
-
-